Skip to content

The Addition of Hydromorphone to Local Anesthetics for the Repair of Inguinal Hernias in Elderly Patients

A Randomized Controlled Study of Ropivacaine Combined With Hydromorphone to Block Lumbar Muscle in Elderly Inguinal Hernia Repair.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06218160
Enrollment
63
Registered
2024-01-23
Start date
2022-11-01
Completion date
2023-12-25
Last updated
2024-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inguinal Hernia

Keywords

hydromorphone, Quadratus lumbois block, old people

Brief summary

To compare the clinical and postoperative analgesic effects of hydromorphone combined with ropivacaine and ropivacaine alone in quadrangular muscle block for open inguinal hernia in elderly patients.

Detailed description

Elderly patients selected for Lichtenstein hernia repair in our hospital who met the inclusion and exclusion criteria and obtained informed consent were included in this trial, and were randomly divided into experimental group by random number table method: 0.375% ropivacaine combined with hydromorphone block group, and control group: 0.375% ropivacaine block group alone.

Interventions

DRUGHydromorphone combined with ropivacaine

1mg hydromorphone was added to 0.375% ropivacaine for a total of 30ml to perform quadrat block

DRUGRopivacaine

A mixture of 0.375% ropivacaine for a total of 30ml was used for quadrate block

Sponsors

Second Hospital of Jilin University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 60 and above. * Admission to hospital for open inguinal hernia surgery is consistent with the -indications of this surgical modality, ASA grades 1 to 3. * No recent use of sedatives, opioids, or other analgesics. * Good compliance, signed informed consent. * Complete clinical data.

Exclusion criteria

* There are serious cardiovascular and cerebrovascular diseases. * Abdominal infection. * Coagulation dysfunction or receiving anticoagulation therapy. * Local anesthesia drug allergy. * Can not cooperate with the corresponding operation, suffering from mental illness. * Previous surgical history of the corresponding position in the abdomen that may interfere with the surgical process of this study.

Design outcomes

Primary

MeasureTime frameDescription
Related indexes of anesthesia effect: pain after surgery, 6, 12, 18,24, 48h after surgery.From the end of surgery until two days after surgery.Visual analogue scale (VAS) was used to score the postoperative pain at 6,12,18,24,48h.The score ranges from 0 (no pain) to 10 (most severe pain). The change was equal to the score difference between the two groups at different observation time points (6,12,18,24,48h).
Related indexes of anesthesia effect: time of onset of anesthesia, duration of anesthesia maintenance.From the start of anesthesia until two days after surgery.The range of the effective time of anesthesia minus the start time of anesthesia and the maintenance time minus the start time of anesthesia are respectively.The unit of time is minutes.

Secondary

MeasureTime frameDescription
The occurrence of postoperative adverse reactions.The operation ended two days after surgery.The rates of postoperative nausea, vomiting and dizziness were compared between the two groups.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026